News summaryJ-Star Holding via GlobeNewswireNov 15, 2026, 12:00 PM
Alpha Tau Medical Announces Positive Interim Results from U.S. REGAIN Trial for Recurrent Glioblastoma
Alpha Tau Medical reported updated interim results from its U.S. REGAIN trial, showing all eight treated patients remain alive with no unanticipated serious adverse events.